» Articles » PMID: 34411689

Advancedoral Vaccine Delivery Strategies for Improving the Immunity

Overview
Specialty Pharmacology
Date 2021 Aug 19
PMID 34411689
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Infectious diseases continue to inflict a high global disease burden. The consensus is that vaccination is the most effective option against infectious diseases. Oral vaccines have unique advantages in the prevention of global pandemics due to their ease of use, high compliance, low cost, and the ability to induce both systemic and mucosal immune responses. However, challenges of adapting vaccines for oral administration remain significant. Foremost among these are enzymatic and pH-dependent degradation of antigens in the stomach and intestines, the low permeability of mucus barrier, the nonspecific uptake of antigens at the intestinal mucosal site, and the immune suppression result from the elusive immune tolerance mechanisms. Innovative delivery techniques promise great potential for improving the flexibility and efficiency of oral vaccines. A better understanding of the delivery approaches and the immunological mechanisms of oral vaccine delivery systems may provide new scientific insight and tools for developing the next-generation oral vaccine. Here, an overview of the advanced technologies in the field of oral vaccination is proposed, including mucus-penetrating nanoparticle (NP), mucoadhesive delivery vehicles, targeting antigen-presenting cell (APC) nanocarriers and enhanced paracellular delivery strategies and so on. Meanwhile, the mechanisms of delivery vectors interact with mucosal barriers are discussed.

Citing Articles

Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines.

Xiao W, Jiang W, Chen Z, Huang Y, Mao J, Zheng W Signal Transduct Target Ther. 2025; 10(1):74.

PMID: 40038239 PMC: 11880366. DOI: 10.1038/s41392-024-02107-5.


Pivotal role of virulence genes in pathogenicity and vaccine development.

Elbehiry A, Marzouk E, Abalkhail A, Sindi W, Alzahrani Y, Alhifani S Front Med (Lausanne). 2025; 11():1523991.

PMID: 39850097 PMC: 11756510. DOI: 10.3389/fmed.2024.1523991.


Overcoming Biopotency Barriers: Advanced Oral Delivery Strategies for Enhancing the Efficacy of Bioactive Food Ingredients.

Liu L, McClements D, Liu X, Liu F Adv Sci (Weinh). 2024; 11(44):e2401172.

PMID: 39361948 PMC: 11600209. DOI: 10.1002/advs.202401172.


Applications of Chitosan in Prevention and Treatment Strategies of Infectious Diseases.

Sinani G, Sessevmez M, Senel S Pharmaceutics. 2024; 16(9).

PMID: 39339237 PMC: 11434819. DOI: 10.3390/pharmaceutics16091201.


Advancements and Challenges in Peptide-Based Cancer Vaccination: A Multidisciplinary Perspective.

Liu D, Liu L, Li X, Wang S, Wu G, Che X Vaccines (Basel). 2024; 12(8).

PMID: 39204073 PMC: 11359700. DOI: 10.3390/vaccines12080950.